MARTINELLI, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 3.232
AS - Asia 2.476
EU - Europa 1.496
SA - Sud America 362
AF - Africa 64
Continente sconosciuto - Info sul continente non disponibili 51
OC - Oceania 8
Totale 7.689
Nazione #
US - Stati Uniti d'America 3.071
CN - Cina 749
SG - Singapore 747
IT - Italia 622
BR - Brasile 272
VN - Vietnam 256
HK - Hong Kong 243
GB - Regno Unito 143
KR - Corea 120
DE - Germania 117
SE - Svezia 101
FI - Finlandia 99
BD - Bangladesh 92
RU - Federazione Russa 87
CA - Canada 74
ID - Indonesia 63
NL - Olanda 56
FR - Francia 53
IN - India 50
LT - Lituania 40
AR - Argentina 34
IE - Irlanda 31
MX - Messico 25
PL - Polonia 25
CZ - Repubblica Ceca 21
IQ - Iraq 21
ZA - Sudafrica 20
AT - Austria 19
JP - Giappone 19
BG - Bulgaria 16
CO - Colombia 15
CR - Costa Rica 14
TR - Turchia 14
UA - Ucraina 14
ES - Italia 13
AE - Emirati Arabi Uniti 12
EG - Egitto 11
JM - Giamaica 11
SA - Arabia Saudita 11
UZ - Uzbekistan 11
EC - Ecuador 9
KE - Kenya 9
MA - Marocco 9
CL - Cile 8
MY - Malesia 8
PK - Pakistan 8
TT - Trinidad e Tobago 8
VE - Venezuela 8
AU - Australia 7
CH - Svizzera 7
PY - Paraguay 6
TN - Tunisia 6
BH - Bahrain 5
GR - Grecia 5
HN - Honduras 5
OM - Oman 5
PH - Filippine 5
TW - Taiwan 5
UY - Uruguay 5
BE - Belgio 4
GP - Guadalupe 4
GT - Guatemala 4
IL - Israele 4
LB - Libano 4
PA - Panama 4
SV - El Salvador 4
TH - Thailandia 4
AZ - Azerbaigian 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
JO - Giordania 3
NO - Norvegia 3
NP - Nepal 3
PS - Palestinian Territory 3
AL - Albania 2
BB - Barbados 2
CY - Cipro 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
HR - Croazia 2
KZ - Kazakistan 2
MK - Macedonia 2
MT - Malta 2
NI - Nicaragua 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AO - Angola 1
CW - ???statistics.table.value.countryCode.CW??? 1
ET - Etiopia 1
HU - Ungheria 1
IS - Islanda 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
Totale 7.634
Città #
Ashburn 487
Singapore 481
Santa Clara 461
San Jose 378
Hefei 335
Hong Kong 241
Council Bluffs 190
Seoul 114
Beijing 95
Los Angeles 90
London 86
Chandler 77
Ho Chi Minh City 77
Milan 68
Hanoi 65
Helsinki 64
Chicago 56
New York 53
The Dalles 50
Jakarta 45
Nyköping 45
Bologna 44
Munich 43
Modena 40
Fairfield 36
Rome 33
Buffalo 31
Shanghai 29
Moscow 26
Toronto 26
Hillsboro 25
Lauterbourg 25
San Diego 25
Dallas 24
Warsaw 22
Frankfurt am Main 21
Atlanta 20
Kent 19
Orem 19
Reggio Emilia 19
São Paulo 19
Houston 18
Lappeenranta 18
Sofia 16
Turku 16
Boardman 14
Brno 14
Woodbridge 14
Amsterdam 13
Cambridge 13
Da Nang 13
Dublin 13
Montreal 13
Seattle 13
Tokyo 13
Brooklyn 12
Florence 12
Naples 12
Phoenix 12
Indianapolis 11
Carrboro 10
Denver 10
Nuremberg 10
Princeton 10
Salt Lake City 10
San José 10
Tashkent 10
Vienna 10
Washington 10
Wilmington 10
Bremen 9
Haiphong 9
Johannesburg 9
Mexico City 9
Tampa 9
Bari 8
Lansdowne 8
Melbourne 8
Nairobi 8
Redondo Beach 8
Turin 8
Buenos Aires 7
Columbus 7
Detroit 7
Newark 7
Poplar 7
Reading 7
Rio de Janeiro 7
Biên Hòa 6
Boston 6
Bắc Ninh 6
Calcinaia 6
Chennai 6
City of London 6
Düsseldorf 6
Kingston 6
Mumbai 6
New Delhi 6
North Bergen 6
Olomouc 6
Totale 4.678
Nome #
Predictors for progression in amyotrophic lateral sclerosis associated to SOD1 mutation: insight from two population-based registries 313
Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy 313
Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis: Clinical Protocol and Evaluation of Microbiota Immunity Axis 292
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trial 270
Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study 261
Ataxia-myoclonus syndrome in patients with SARS-CoV2 infection 259
Duplication of exons 15 and 16 in Matrin-3: a phenotype bridging amyotrophic lateral sclerosis and immune-mediated disorders 246
SerpinA1 levels in amyotrophic lateral sclerosis patients: An exploratory study 240
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 240
A novel p.N66T mutation in exon 3 of the SOD1 gene: report of two families of ALS patients with early cognitive impairment 226
Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggressive disease phenotype 221
Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules 219
Mitochondrial and Endoplasmic Reticulum Alterations in a Case of Amyotrophic Lateral Sclerosis Caused by TDP-43 A382T Mutation 214
Factors predicting disease progression in C9ORF72 ALS patients 209
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data 208
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study. 205
Insight into Elderly ALS Patients in the Emilia Romagna Region: Epidemiological and Clinical Features of Late-Onset ALS in a Prospective, Population-Based Study 200
TeleNeurological evaluation and Support for the Emergency Department (TeleNS-ED): protocol for an open-label clinical trial 194
Correction to: Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS): validation and longitudinal performance (Journal of Neurology, (2023), 270, 3, (1452-1456), 10.1007/s00415-022-11483-3) 191
Correction to: Retrospective observational study on the use of acetyl-L-carnitine in ALS 188
A Variant in TBCD Associated with Motoneuronopathy and Corpus Callosum Hypoplasia: A Case Report 186
CSF Heavy Neurofilament May Discriminate and Predict Motor Neuron Diseases with Upper Motor Neuron Involvement 185
Young Onset Alzheimer’s Disease Associated with C9ORF72 Hexanucleotide Expansion: Further Evidence for a Still Unsolved Association 184
The association between lifelong personality and clinical phenotype in the FTD-ALS spectrum 183
Retrospective observational study on the use of acetyl-l-carnitine in ALS 183
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 180
Multifaceted superoxide dismutase 1 expression in amyotrophic lateral sclerosis patients: a rare occurrence? 176
The gut microbiota-immunity axis in als: A role in deciphering disease heterogeneity? 175
G507D mutation in FUS gene causes familial amyotrophic lateral sclerosis with a specific genotype-phenotype correlation. 172
Trends in Hospital Admissions for Patients with Amyotrophic Lateral Sclerosis: Insights from a Retrospective Cohort Study in a Province in Northern Italy 161
Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS): validation and longitudinal performance 156
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis 156
Exploring the Role of Diabetes in ALS: A Population-Based Cohort Study 144
The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis 140
Tregs levels and phenotype modifications during Amyotrophic Lateral Sclerosis course 135
Predictors from systemic and neuro-inflammation in amyotrophic lateral sclerosis: A monocentric experience 128
Predittori clinici e biologici per la Sclerosi Laterale Amiotrofica: uno studio monocentrico 124
Withdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey 114
Circulating Serum Cell-Free Mitochondrial DNA in Amyotrophic Lateral Sclerosis 98
Totale 7.689
Categoria #
all - tutte 33.824
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.824


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022229 0 0 0 0 21 10 9 2 67 25 63 32
2022/2023255 27 30 16 17 34 30 8 28 31 4 10 20
2023/2024498 6 9 31 44 59 22 76 50 14 41 56 90
2024/20251.826 41 21 60 147 304 259 138 59 221 94 217 265
2025/20263.784 350 214 345 446 418 170 482 259 368 394 196 142
2026/20271.078 203 224 297 354 0 0 0 0 0 0 0 0
Totale 7.689